Publicaciones en las que colabora con Joan Valls (12)

2016

  1. 2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

    Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371

  2. Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer

    Molecular Imaging and Biology, Vol. 18, Núm. 4, pp. 545-556

  3. Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer

    Oncotarget, Vol. 7, Núm. 19, pp. 26979-26991

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

2014

  1. A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403

  2. Combinatorial therapy using dovitinib and ICI182.780 (Fulvestrant) blocks tumoral activity of endometrial cancer cells

    Molecular Cancer Therapeutics, Vol. 13, Núm. 4, pp. 776-787

  3. Optimal protocol for PTEN immunostaining; Role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

    Human Pathology, Vol. 45, Núm. 3, pp. 522-532

  4. Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma

    Laboratory Investigation, Vol. 94, Núm. 6, pp. 608-622

2012

  1. Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

    Molecular Oncology, Vol. 6, Núm. 5, pp. 530-541

  2. Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

    International Journal of Cancer, Vol. 130, Núm. 4, pp. 967-978

2011

  1. FGFR2 alterations in endometrial carcinoma

    Modern Pathology, Vol. 24, Núm. 11, pp. 1500-1510

  2. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma

    Human Pathology, Vol. 42, Núm. 2, pp. 185-193